Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
APOMORPHINE HYDROCHLORIDE
Genus Pharmaceuticals Limited
APOMORPHINE HYDROCHLORIDE
10 Mg/Ml
Solution for Inj/Inf
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
Page 1 of 10 APO-GO ® AMPOULES 10MG/ML SOLUTION FOR INJECTION* APOMORPHINE HYDROCHLORIDE For use in adults PACKAGE LEAFLET: INFORMATION FOR THE USER * _Abbreviated to_ APO-go Ampoules_ in the text_ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, nurse or pharmacist. This medicine has been prescribed for you. Do not give it to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. IN THIS LEAFLET: 1. What APO-go Ampoules is and what it is used for 2. Before you use APO-go Ampoules 3. How to use APO-go Ampoules 4. Possible side effects 5. How to store APO-go Ampoules 6. Further information 1. WHAT APO-GO AMPOULES IS AND WHAT IT IS USED FOR APO-go Ampoules contains apomorphine solution for injection. It is injected into the area under the skin (subcutaneously). The active ingredient in APO-go Ampoules is apomorphine hydrochloride. There is 10 mg of apomorphine in each millilitre of solution. Apomorphine hydrochloride belongs to a group of medicines known as dopamine agonists. APO- go Ampoules is used to treat Parkinson's disease. Apomorphine helps reduce the amount of time spent in an „off‟ or immobile state in people who have previously been treated for Parkinson‟s disease with levodopa (another treatment for Parkinson‟s disease) and/or other dopamine agonists. Your doctor or nurse will help you to recognise the signs of when to use your medicine. Despite the name, apomorphine does not contain morphine. 2. BEFORE YOU USE APO-GO AMPO Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT APO-go AMPOULES 10 mg/ml Solution for Injection or Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1ml contains 10mg apomorphine hydrochloride 2ml contains 20mg apomorphine hydrochloride 5ml contains 50mg apomorphine hydrochloride Excipient: Sodium metabisulphite (E223) 1mg per ml For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for Injection or Infusion Clear, colourless or almost colourless, practically free from visible particles pH 3.0-4.0 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral anti-Parkinson medication. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Selection of Patients suitable for APO-go injections:_ Patients selected for treatment with APO-go should be able to recognise the onset of their ‘off’ symptoms and be capable of injecting themselves or else have a responsible carer able to inject for them when required. It is essential that the patient is established on domperidone, usually 20mg three times daily, for at least two days prior to initiation of therapy. Apomorphine should be initiated in the controlled environment of a specialist clinic. The patient should be supervised by a physician experienced in the treatment of Parkinson’s disease (e.g. neurologist). The patient’s treatment with levodopa, with or without dopamine agonists, should be optimised before starting APO-go treatment. ADULTS _Administration_ APO-go Ampoules 10 mg/ml Solution for Injection or Infusion is for subcutaneous use by intermittent bolus injection. APO-go Ampoules 10 mg/ml Solution for Injection or Infusion may also be administered as a continuous subc Read the complete document